The CDC has announced that its voluntary Traveler-Based Genomic Surveillance program has reached over one million participants. This program aims to monitor the spread of infectious diseases through air travel by collecting and analyzing genomic data from willing participants. The findings from this large-scale biosurveillance effort may provide valuable insights, though the specific details and implications are unclear from the limited information provided.